tirzepatide as compared with semaglutide for the treatment of obesity on ingestive behavior in adults overweight or obesity: a randomized 6-week phase 1 trial Original Article: Tirzepatide as Compared

NICE guidance on eating disorders (NG69) emphasises early intervention and recommends referral to specialist eating disorder services when appropriate

This higher-dose strength is designed for eligible patients who may benefit from an additional step-up in their clinical journey without the need to switch brands or care pathways

These include: Delaware Kansas Massachusetts Michigan Minnesota Mississippi Missouri North Carolina Rhode Island Tennessee Utah Virginia Wisconsin Four states have entirely eliminated coverage for GLP-1s for weight loss as of January 2026

5***** from me Had a problem with my order but it was immediately sorted & they sent me extra goodies